Atlas Trials

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Clinical trial NCT02175342 · COMPLETED

Trial details

NCT number
NCT02175342
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
1998-03-01
Primary completion
1999-04-01
Enrollment
202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.